XLMM

IP属地:未知
    • XLMMXLMM
      ·2022-01-14
      That is some analysis!
      非常抱歉,此主贴已删除
      618评论
      举报
    • XLMMXLMM
      ·2022-01-13
      cant wait for their earning report...
      非常抱歉,此主贴已删除
      878评论
      举报
    • XLMMXLMM
      ·2022-01-12
      Go go go!
      非常抱歉,此主贴已删除
      5361
      举报
    • XLMMXLMM
      ·2022-01-12
      Awesome! 
      非常抱歉,此主贴已删除
      618评论
      举报
    • XLMMXLMM
      ·2022-01-12
      And yes we have one of them today...South Korea! Yay!
      非常抱歉,此主贴已删除
      495评论
      举报
    • XLMMXLMM
      ·2022-01-11
      heavy discounts for the shares we love! 
      非常抱歉,此主贴已删除
      8151
      举报
    • XLMMXLMM
      ·2022-01-07
      Looks like Singapore is considering their vaccine too..
      非常抱歉,此主贴已删除
      594评论
      举报
    • XLMMXLMM
      ·2022-01-04
      Have been buying the dips!
      非常抱歉,此主贴已删除
      899评论
      举报
    • XLMMXLMM
      ·2022-01-04
      Awesome! looks like several investment sites are starting to raise their price target for NVAX. 
      非常抱歉,此主贴已删除
      390评论
      举报
    • XLMMXLMM
      ·2022-01-01
      $Novavax(NVAX)$‌For those who are confused with the submisson of final data package and EUA application:31st Dec 2021: Chemistry, manufacturing and controls (CMC) data module submitted to U.S. Food and Drug Administration (FDA), completing final data packages required for emergency use authorization (EUA) application for Novavax' COVID-19 vaccine By 31st Jan 2022: UA application request to be submitted following one month required by FDA EUA guidancehttps://ir.novavax.com/2021-12-31-Novavax-Submits-Final-Data-Packages-to-U-S-FDA-as-Prerequisite-to-Emergency-Use-Authorization-Application-Request-for-COVID-19-Vaccine
      909评论
      举报
     
     
     
     

    热议股票